New Camera-Based Imaging Offers Objective Assessment of Scleroderma Skin Scarring

A new non-invasive technology, spatial frequency domain imaging (SFDI), has demonstrated its ability to objectively quantify collagen in the skin of scleroderma patients. This development could lead to earlier diagnosis, more reliable tracking of skin changes in clinical trials, and improved treatment outcomes for this autoimmune disease.